The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs.
Starting Wednesday, eligible beneficiaries can get GLP-1s to treat o… [+15066 chars]
Discussion (0)
No comments yet. Be the first to share your thoughts!
Join the Conversation
You need to be logged in to leave a comment.
Sign In Create Account